Multiple Dana-Farber Cancer Institute Studies Retracted After Data Manipulation Detected
The reputation of the prestigious Harvard University-affiliated Dana-Farber Cancer Institute (DFCI) in Boston, Massachusetts is at stake after seven studies were retracted from the medical literature and over 30 papers were subject to corrections due to errors. The allegations, which involve image duplications and manipulations in biomedical research, first surfaced in January 2024 when microbiologist […]
Big Pharma’s Revolving Door With Government Health Agencies
More than half of the staff at the U.S. Centers for Disease Control and Prevention (CDC) go to work for pharmaceutical giants when they leave the government, according to a new report by researchers at the University of Southern California and Harvard University. The report showed that eight percent of the CDC staff came from […]
Tamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]
Google Joins the Pharmaceutical Industry
Story Highlights Google, the world’s most widely used internet search engine, restructured itself to give semi-independence to its many subsidiary organizations under a new umbrella entity called Alphabet. Two of the divisions are focused on the business of medicine and operate in partnership with some of the world’s most powerful pharmaceutical companies that develop and […]
